Amelie D.
- Country
- Belgium
- Department
- Oncology
Research Overview
- Evaluation of Short-Course Radiotherapy Versus Total Neoadjuvant Therapy in Elderly Patients with Locally Advanced Rectal Cancer: A Randomized Clinical Trial
- Phase II Study of Neoadjuvant Regorafenib and Nivolumab with Short-Course Radiotherapy in Intermediate-Risk Stage II-III Rectal Cancer
- Efficacy of Zolbetuximab Plus mFOLFOX6 Versus Placebo Plus mFOLFOX6 in Claudin 18.2-Positive, HER2-Negative Metastatic Gastric or GEJ Adenocarcinoma
Data & Insights
Has run more than one trial at 8 of 33 partner sites.
Specializations
Gastrointestinal Oncology
Specializes in advanced treatments for gastric and gastroesophageal junction adenocarcinoma, with particular focus on innovative targeted therapies for patients with specific molecular markers like CLDN18.2-positive and HER2-negative tumors.
- Advanced Gastric Cancer Treatment
- Molecular-Targeted Therapy
- First-line Treatment Strategies
Colorectal Cancer Management
Focuses on developing treatment approaches for locally advanced rectal cancer, with special emphasis on adapting therapeutic strategies for older patient populations. Explores the effectiveness of short-course radiotherapy in various treatment combinations.
- Neoadjuvant Treatment Strategies
- Age-Adapted Therapy Protocols
- Combined Modality Treatment
Innovative Cancer Therapeutics
Investigates novel combination approaches incorporating immunotherapy and targeted agents in the treatment of intermediate-risk rectal cancer. Specializes in integrating multiple treatment modalities including radiotherapy and systemic therapies.
- Immunotherapy Integration
- Multi-modal Treatment Approaches
- Response Assessment Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.